Issues related to tamper-resistant formulation of pharmaceutical drugs; Life Sciences Jobs and Investment Act. H.R. 160, Protect Medical Innovation Act of 2015; issues relating to international tax code; issues relating to foreign earnings. Oversight of implementation of the America Invents Act; issues relating to patent settlements; issues relating to data exclusivity; H.R. 9, the Innovation Act. Issues relating to prescription drug abuse; issues relating to incentives for tamper-resistant formulations; issues relating to Medicare Part D rebates; compounding and drug supply chain legislation; H.R. 471, Ensuring Patient Access and Effective Drug Enforcement Act of 2015; issues relating to the labeling of generic drugs; issues relating to eliminating Medicare coverage for prosthetic urological interventions, including H. Res. 106; issues related to REMS and physician certification for controlled substance prescribing; issues related to registration of controlled substances overseas.
PHA - Pharmacy TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
ENDO INTERNATIONAL
1400 Atwater Drive, Malvern, PA, 19355, US
JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT JAMES BRIAN MUNROE ANDREW SCOTT